NR3C2 and type 2 diabetes mellitus: The efficacy of MR blockade in reducing vascular permeability has previously been demonstrated in the renal microcirculation of patients with type 1 and type 2 diabetes [55,56,57,58], as well as in STZ rats and db/db mice [39].